Skip to content

Nexpowder™

by Nextbiomedical Co., Ltd. South Korea EUDAMED

Ref UI-EWD2

EMDN G020499

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-08800038404366 Basic UDI-DIDate28 Dec 2023RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/MDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 23 Oct 2026

Model / Reference
UI-EWD2
Primary DI / UDI-DI
08800038404366
Basic UDI-DI
B-08800038404366
EMDN Code
G020499 Gastrointestinal haemostasis devices - other
Device Class
Class III
Market of Registration
Netherlands

Manufacturer details

EUDAMED SRN
KR-MF-000004808
Authorised representative
Obelis s.a. BE-AR-000000106

Other devices from Nextbiomedical Co., Ltd.

See all devices from Nextbiomedical Co., Ltd. →

Properties & raw data

Show properties, registry sources and raw records
  • Sterile
Other properties (10)
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED 07d1b56a-dcc7-4374-b36f-7f9b3e4788f4 61 fields · synced 23 Oct 2026